ANALYSIS OF THE INCIDENCE OF MYOCARDIAL INFARCTION IN THE CARDIOLOGY CENTER IN SHYMKENT
Background. Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide [11]. An estimated 23.6 million people a year will die from cardiovascular disease by 2030 [6]. Over the past three decades, there has been a sharp decline in mortality from cardiovascular diseases among both men and women, especially in the age group > 65 years old [7].
The aim of the work is to study the incidence of myocardial infarction in the Cardiological Center in Shymkent.
Materials and methods. In the course of the study, the analysis of statistical data of the Cardiology Department of the Cardiology Center in Shymkent was carried out. The following indicators were analyzed for the period 2017-2019: incidence, re-hospitalization rate, bed-days, etc.
Results. In 2017-2019, 6230 patients were admitted to the Cardiology Department of the Cardiology Center. In 2017, the number of patients admitted with myocardial infarction was 1528 (77.6), in 2018 - 1700 (86.3), in 2019 - 1562 (79.3). In 2018, there is a tendency towards an increase in the number of admitted patients with myocardial infarction by 10% compared to 2017 and a decrease by 8% compared to 2019. Over the years under study (2017-2019), 712 patients with recurrent myocardial infarction were admitted to the Cardiology Department of the Cardiology Center. In the dynamics, there is a tendency to an increase in the rate of admissions of patients with recurrent myocardial infarction by 4.2 times: from 3.9 (78 cases) in 2017 to 16.7 (329 cases) in 2018. There is a slight decrease in this indicator to 15.4 (305 cases) in 2019.
Conclusion. Thus, in the Cardiology Center in Shymkent, myocardial infarction occurs in 97% of cases of the total number of cardiovascular diseases. There has been a decrease in bed-days of patients with myocardial infarction from 8.8 in 2017 to 7.9 in 2019. Most often, patients with myocardial infarction are readmitted after stenting (62.5%).
Zhanat U. Sadibekova1, https://orcid.org/0000-0003-1789-1834
Gulzat Z. Sarsenbayeva1, https://orcid.org/0000-0002-1518-6528
Bakhyt B. Tokkuliyeva1, https://orcid.org/0000-0002-5964-1430
Zaituna A. Khismetova2, https://orcid.org/0000-0001-5937-3045
Kasymkhan A. Sultanbekov1, https://orcid.org/0000-0003-0973-8397
Dariga S. Smailova3, http://orcid.org/0000-0002-7152-7104
1 JSC «South Kazakhstan Medical Academy», Shymkent city, the Republic of Kazakhstan;
2 NCJSC «Semey Medical University», Semey city, the Republic of Kazakhstan;
3 Kazakhstan’s Medical University «Kazakhstan School of Public Health», Almaty, Republic of Kazakhstan.
1. Жунусова Д.К., Бекбергенова Ж.Б., Киспаева Т.Т. Сердечная реабилитация. Адаптированное клиническое сестринское руководство, 2020. 76 c.
2. Сейсембеков Т.З. Сердечно-сосудистая заболеваемость и смертность взрослого населения г.Астана // Медицина. 2018. Т. 11. № 197. С. 28–35.
3. Информационные системы здравоохранения Республики Казахстан [Электронный ресурс]. URL: http://ezdrav.kz/posetitelyam/kratkoe-opisanie-informatsionnykh-sistem (дата обращения: 09.03.2021).
4. Akimbaeva Z., Ismailov Z., Akanov A.A., Radišauskas R, Padaiga Ž. Assessment of coronary care management and hospital mortality from ST-segment elevation myocardial infarction in the Kazakhstan population: Data from 2012 to 2015. Med. 2017;53(1):58-65. doi:10.1016/j.medici.2017.01.006.
5. Chung S.C., Gedeborg R., Nicholas O. et al. Acute myocardial infarction: A comparison of short-term survival in national outcome registries in Sweden and the UK. Lancet. 2014;383(9925):1305-1312. doi:10.1016/S0140-6736(13)62070-X.
6. Francula-Zaninovic S., Nola I.A. Management of Measurable Variable Cardiovascular Disease’ Risk Factors. Curr Cardiol Rev. 2018;14(3):153-163. doi:10.2174/1573403x14666180222102312.
7. Garcia M., Mulvagh S.L., Merz C.N., Buring J.E., Manson J.A. Cardiovascular disease in women: Clinical perspectives. Circ Res. 2016;118(8):1273-1293. doi:10.1161/CIRCRESAHA.116.307547.
8. Javaheri S., Redline S. Insomnia and Risk of Cardiovascular Disease. Chest. 2017;152(2):435-444. doi:10.1016/j.chest.2017.01.026.
9. Kim Y., Ahn Y., Cho M.C., Kim C.J., Kim Y.J., Jeong M.H. Current status of acute myocardial infarction in Korea. Korean J Intern Med. 2019;34(1):1-10. doi:10.3904/kjim.2018.381.
10. Lee H.Y., Oh B.H. Heart transplantation in Asia. Circ J. 2017;81(5):617-621. doi:10.1253/circj.CJ-17-0162.
11. Nitsa A., Toutouza M., Machairas N., Mariolis A., Philippou A., Koutsilieris M. Vitamin D in cardiovascular disease. In Vivo (Brooklyn). 2018;32(5):977-981. doi:10.21873/invivo.11338.
12. Roos-Hesselink J., Baris L., Johnson M., et al. Pregnancy outcomes in women with cardiovascular disease: Evolving trends over 10 years in the ESC Registry of Pregnancy and Cardiac disease (ROPAC). Eur Heart J. 2019;40(47):3848-3855. doi:10.1093/eurheartj/ehz136.
13. De Rosa S., Spaccarotella C., Basso C., et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J. 2020;41(22):2083-2088. doi:10.1093/eurheartj/ehaa409.
14. Saeed A., Kampangkaew J., Nambi V. Prevention of Cardiovascular Disease in Women. Methodist Debakey Cardiovasc J. 2017;13(4):185-192. doi:10.14797/mdcj-13-4-185.
15. Schmidt M., Maeng M., Madsen M., Sørensen H.T., Jensen L.O., Jakobsen C.J. The Western Denmark Heart Registry: Its Influence on Cardiovascular Patient Care. J Am Coll Cardiol. 2018;71(11):1259-1272. doi:10.1016/j.jacc.2017.10.110.
References:
1. Zhunusova D.K., Bekbergenova Zh.B., Kispaeva T.T. Serdechnaya reabilitatsiya. Adaptirovannoe klinicheskoe sestrinskoe rukovodstvo [Cardiac rehabilitation. Adapted clinical nursing guidelines], 2020. 76p. [in Russian]
2. Sejsembekov T.Z. Serdechno-sosudistaya zabolevaemost' i smertnost' vzroslogo naseleniya g.Astana [Cardiovascular morbidity and mortality of the adult population in Astana]. Meditsina [Medicine]. 2018. T. 11. № 197. pp. 28–35. [in Russian]
3. Informatsionnye sistemy zdravookhraneniya Respubliki Kazahstan [Jelektronnyj resurs]. [Health information systems of the Republic of Kazakhstan]. URL: http://ezdrav.kz/posetitelyam/kratkoe-opisanie-informatsionnykh-sistem (data obrashhenija: 09.03.2021). [in Russian]
4. Akimbaeva Z., Ismailov Z., Akanov A.A., Radišauskas R., Padaiga Ž. Assessment of coronary care management and hospital mortality from ST-segment elevation myocardial infarction in the Kazakhstan population: Data from 2012 to 2015. Med. 2017;53(1):58-65. doi:10.1016/j.medici.2017.01.006.
5. Chung S.C., Gedeborg R., Nicholas O., et al. Acute myocardial infarction: A comparison of short-term survival in national outcome registries in Sweden and the UK. Lancet. 2014;383(9925):1305-1312. doi:10.1016/S0140-6736(13)62070-X.
6. Francula-Zaninovic S., Nola I.A. Management of Measurable Variable Cardiovascular Disease’ Risk Factors. Curr Cardiol Rev. 2018;14(3):153-163. doi:10.2174/1573403x14666180222102312.
7. Garcia M., Mulvagh S.L., Merz C.N., Buring J.E., Manson J.A. Cardiovascular disease in women: Clinical perspectives. Circ Res. 2016;118(8):1273-1293. doi:10.1161/CIRCRESAHA.116.307547.
8. Javaheri S., Redline S. Insomnia and Risk of Cardiovascular Disease. Chest. 2017;152(2):435-444. doi:10.1016/j.chest.2017.01.026.
9. Kim Y., Ahn Y., Cho M.C., Kim C.J., Kim Y.J., Jeong MH. Current status of acute myocardial infarction in Korea. Korean J Intern Med. 2019;34(1):1-10. doi:10.3904/kjim.2018.381.
10. Lee H.Y., Oh B.H. Heart transplantation in Asia. Circ J. 2017;81(5):617-621. doi:10.1253/circj.CJ-17-0162.
11. Nitsa A., Toutouza M., Machairas N., Mariolis A., Philippou A., Koutsilieris M.. Vitamin D in cardiovascular disease. In Vivo (Brooklyn). 2018;32(5):977-981. doi:10.21873/invivo.11338.
12. Roos-Hesselink J., Baris L., Johnson M. et al. Pregnancy outcomes in women with cardiovascular disease: Evolving trends over 10 years in the ESC Registry of Pregnancy and Cardiac disease (ROPAC). Eur Heart J. 2019;40(47):3848-3855. doi:10.1093/eurheartj/ehz136.
13. De Rosa S., Spaccarotella C., Basso C., et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J. 2020;41(22):2083-2088. doi:10.1093/eurheartj/ehaa409.
14. Saeed A., Kampangkaew J, Nambi V. Prevention of Cardiovascular Disease in Women. Methodist Debakey Cardiovasc J. 2017;13(4):185-192. doi:10.14797/mdcj-13-4-185.
15. Schmidt M., Maeng M., Madsen M., Sørensen H.T., Jensen L.O., Jakobsen C.J. The Western Denmark Heart Registry: Its Influence on Cardiovascular Patient Care. J Am Coll Cardiol. 2018;71(11):1259-1272. doi:10.1016/j.jacc.2017.10.110.
Количество просмотров: 507
Категория статей:
Оригинальные исследования
Библиографическая ссылка
Sadibekova Zh.U., Sarsenbayeva G.Z., Tokkuliyeva B.B., Khismetova Z.A., Sultanbekov K.A., Smailova D.S. Analysis of the incidence of myocardial infarction in the Cardiology Center in Shymkent // Nauka i Zdravookhranenie [Science & Healthcare]. 2021, (Vol.23) 2, pp. 127-132. doi 10.34689/SH.2021.23.2.013Похожие публикации:
МЕХАНИКАЛЫҚ САРҒАЮ ОПЕРАЦИЯСЫ КЕЗІНДЕ КОАГУЛОПАТИЯЛЫҚ ҚАН КЕТУДІҢ АЛДЫН АЛУ ӘДІСІ
ОПТИМИЗАЦИЯ РЕЗУЛЬТАТОВ АУТОДЕРМОПЛАСТИКИ ПРИ ЛЕЧЕНИИ ГРАНУЛИРУЮЩИХ ГНОЙНЫХ РАН
BASICS OF REHABILITATION OF CHILDREN AFTER OPERATIONS ON THE COLON AND ANORECTAL AREA
HEALTH INDICATORS OF FIRST-YEAR-OF-LIFE CHILDREN IN THE REPUBLIC OF KAZAKHSTAN FOR 2013-2022
ОЦЕНКА УДОВЛЕТВОРЕННОСТИ ТРУДОВОЙ ДЕЯТЕЛЬНОСТЬЮ ВРАЧЕЙ АНЕСТЕЗИОЛОГОВ-РЕАНИМАТОЛОГОВ ГОРОДА АСТАНА